DK135766B - Analogifremgangsmåde til fremstilling af isoquinoliner. - Google Patents

Analogifremgangsmåde til fremstilling af isoquinoliner.

Info

Publication number
DK135766B
DK135766B DK514874AA DK514874A DK135766B DK 135766 B DK135766 B DK 135766B DK 514874A A DK514874A A DK 514874AA DK 514874 A DK514874 A DK 514874A DK 135766 B DK135766 B DK 135766B
Authority
DK
Denmark
Prior art keywords
isoquinolines
preparation
analogous process
analogous
Prior art date
Application number
DK514874AA
Other languages
English (en)
Other versions
DK135766C (da
DK514874A (da
Inventor
Franz Troxler
Erik Wiskott
Original Assignee
Sandoz Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz Ag filed Critical Sandoz Ag
Publication of DK514874A publication Critical patent/DK514874A/da
Publication of DK135766B publication Critical patent/DK135766B/da
Application granted granted Critical
Publication of DK135766C publication Critical patent/DK135766C/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D263/00Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/04Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D263/06Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hydrocarbon radicals, substituted by oxygen atoms, attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D217/00Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/22Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the nitrogen-containing ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D217/00Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/22Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the nitrogen-containing ring
    • C07D217/24Oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D333/00Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/06Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
    • C07D333/24Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
DK514874AA 1973-10-08 1974-09-30 Analogifremgangsmåde til fremstilling af isoquinoliner. DK135766B (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH1430773A CH581113A5 (da) 1973-10-08 1973-10-08

Publications (3)

Publication Number Publication Date
DK514874A DK514874A (da) 1975-06-09
DK135766B true DK135766B (da) 1977-06-20
DK135766C DK135766C (da) 1977-11-21

Family

ID=4399720

Family Applications (1)

Application Number Title Priority Date Filing Date
DK514874AA DK135766B (da) 1973-10-08 1974-09-30 Analogifremgangsmåde til fremstilling af isoquinoliner.

Country Status (21)

Country Link
JP (1) JPS5082078A (da)
AT (1) ATA802974A (da)
AU (2) AU498889B2 (da)
BE (1) BE820789A (da)
CA (1) CA1021772A (da)
CH (1) CH581113A5 (da)
DD (1) DD114605A5 (da)
DE (1) DE2447756A1 (da)
DK (1) DK135766B (da)
ES (1) ES430759A1 (da)
FI (1) FI286374A (da)
FR (1) FR2247242B1 (da)
GB (1) GB1474775A (da)
HU (1) HU169126B (da)
IL (1) IL45797A (da)
NL (1) NL7413105A (da)
NO (1) NO743534L (da)
PH (1) PH11611A (da)
SE (1) SE7412310L (da)
SU (1) SU567403A3 (da)
ZA (1) ZA746409B (da)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI760704A (da) * 1975-03-26 1976-09-27 Sandoz Ag
US4129565A (en) * 1975-07-11 1978-12-12 Nisshin Flour Milling Co., Ltd. Isocarbostyril derivatives
SE7804318L (sv) * 1977-05-02 1978-11-03 Merck & Co Inc Nya naftyridiner
EP0711804A3 (de) 1994-11-14 1999-09-22 Ciba SC Holding AG Kryptolichtschutzmittel
US6346536B1 (en) 1997-09-03 2002-02-12 Guilford Pharmaceuticals Inc. Poly(ADP-ribose) polymerase inhibitors and method for treating neural or cardiovascular tissue damage using the same
US6514983B1 (en) 1997-09-03 2003-02-04 Guilford Pharmaceuticals Inc. Compounds, methods and pharmaceutical compositions for treating neural or cardiovascular tissue damage
US6426415B1 (en) 1997-09-03 2002-07-30 Guilford Pharmaceuticals Inc. Alkoxy-substituted compounds, methods and compositions for inhibiting parp activity
US6635642B1 (en) 1997-09-03 2003-10-21 Guilford Pharmaceuticals Inc. PARP inhibitors, pharmaceutical compositions comprising same, and methods of using same
US6197785B1 (en) * 1997-09-03 2001-03-06 Guilford Pharmaceuticals Inc. Alkoxy-substituted compounds, methods, and compositions for inhibiting PARP activity
US6291425B1 (en) 1999-09-01 2001-09-18 Guilford Pharmaceuticals Inc. Compounds, methods and pharmaceutical compositions for treating cellular damage, such as neural or cardiovascular tissue damage
US6395749B1 (en) 1998-05-15 2002-05-28 Guilford Pharmaceuticals Inc. Carboxamide compounds, methods, and compositions for inhibiting PARP activity
US6387902B1 (en) 1998-12-31 2002-05-14 Guilford Pharmaceuticals, Inc. Phenazine compounds, methods and pharmaceutical compositions for inhibiting PARP
AU2001264595A1 (en) 2000-05-19 2001-12-03 Guilford Pharmaceuticals Inc. Sulfonamide and carbamide derivatives of 6(5h)phenanthridinones and their uses
AU2001275085A1 (en) 2000-06-01 2001-12-11 Guilford Pharmaceuticals Inc. Methods, compounds and compositions for treating gout

Also Published As

Publication number Publication date
GB1474775A (en) 1977-05-25
ZA746409B (en) 1976-05-26
CH581113A5 (da) 1976-10-29
ATA802974A (de) 1979-07-15
NO743534L (da) 1975-05-05
NL7413105A (nl) 1975-04-10
DE2447756A1 (de) 1975-04-10
AU7408974A (en) 1976-04-15
CA1021772A (en) 1977-11-29
IL45797A (en) 1978-04-30
DD114605A5 (da) 1975-08-12
DK135766C (da) 1977-11-21
PH11611A (en) 1978-04-12
ES430759A1 (es) 1977-04-16
AU7409074A (en) 1976-04-15
AU7413074A (en) 1976-04-15
SU567403A3 (ru) 1977-07-30
IL45797A0 (en) 1974-12-31
HU169126B (da) 1976-09-28
DK514874A (da) 1975-06-09
AU498889B2 (en) 1979-03-29
SE7412310L (da) 1975-04-09
FR2247242B1 (da) 1978-07-21
BE820789A (fr) 1975-04-07
FR2247242A1 (da) 1975-05-09
JPS5082078A (da) 1975-07-03
FI286374A (da) 1975-04-09

Similar Documents

Publication Publication Date Title
DK136718B (da) Analogifremgangsmåde til fremstilling af substituerede hexahydro-dibenzo(b,d)-pyran-9-oner.
DK134345B (da) Analogifremgangsmåde til fremstilling af 4-hydroxymethyl-1-phthalazonderivater.
DK136719B (da) Analogifremgangsmåde til fremstilling af substituerede hexahydro-dibenzo(b,d)-pyraner.
DK135376B (da) Fremgangsmåde til fremstilling af piperazinylquinazolin-forbindelser.
DK140484B (da) Fremgangsmåde til fremstilling af zeaxanthin.
DK135766B (da) Analogifremgangsmåde til fremstilling af isoquinoliner.
DK134031B (da) Fremgangsmåde til fremstilling af et endo-beta-glucanase-præparat.
DK139678B (da) Fremgangsmåde til fremstilling af 2,2,6,6-tetramethyl-4-oxopiperidin.
DK140406B (da) Fremgangsmåde til fremstilling af 2,2,6,6-tetramethyl-4-oxopiperidin.
DK137389B (da) Analogifremgangsmåde til fremstilling af 11beta-substituerede delta4-østrener.
DK133977B (da) Fremgangsmåde til fremstilling af 2-chlor-5-sulfamoylbenzoesyrer.
DK135723B (da) Analogifremgangsmåde til fremstilling af 7alfa-acylthio-3-oxo-D-homo-21,24-dinor-17aalfa-chlo-4-en-23,17a-lactoner.
DK137577B (da) Fremgangsmåde til fremstilling af zeaxanthin.
DK139716B (da) Analogifremgangsmåde til fremstilling af 4-aminoamfetaminderivater.
DK137043B (da) Analogifremgangsmåde til fremstilling af nitrocarbostyrilforbindelser.
DK132328B (da) Analogifremgangsmåde til fremstilling af 17beta-hydroxy-16,16-dimethylestr-4-en-3-on.
DK140411B (da) Fremgangsmåde til fremstilling af deacetoxycephalosporin C.
DK131575B (da) Analogifremgangsmåde til fremstilling af 2beta-hydroxy-3alfa-aminosteroider.
DK136602B (da) Fremgangsmåde til fremstilling af farvet mangan-ethylen-bis-dithiocarbamat (maneb).
DK135166B (da) Analogifremgangsmåde til fremstilling af 2-methyl-5-nitro-imidazoler.
DK129657B (da) Analogifremgangsmåde til fremstilling af 3-methylpyrazol-5-carboxamider.
DK136619B (da) Fremgangsmåde til fremstilling af dihydrokanadensolid.
DK139910B (da) Analogifremgangsmåde til fremstilling af substituerede triazoler.
DK134236B (da) Analogifremgangsmåde til fremstilling af 3-cycloalkoxy-16alfa-cyanopregn-5-en-20-oner.
DK132410B (da) Analogifremgangsmåde til fremstilling af 2-amino-4H-pyraner.